Doxil/Caelyx BE Study
- Conditions
- Interventions
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT05567601
- Locations
- 🇮🇳
Erode Cancer Centre, Erode, Tamil Nadu, India
🇮🇳Indrayani Hospital, Pune, Maharashtra, India
🇮🇳Medstar Speciality, Bangalore, Karnataka, India
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
- Conditions
- Interventions
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT05399537
- Locations
- 🇺🇸
University of Southern California (USC) / Keck Hospital, Los Angeles, California, United States
🇺🇸University of California Los Angeles, Los Angeles, California, United States
🇺🇸VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States
Oscillation and Lung Expansion (OLE) for Treatment of Neuromuscular Disease Patients
- Conditions
- Interventions
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 41
- Registration Number
- NCT05366010
- Locations
- 🇺🇸
Science 37, Durham, North Carolina, United States
DermaClose DUKE Fasciotomy and Wound Study
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 70
- Registration Number
- NCT05330767
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Theranova Randomized, Controlled, Trial (RCT) in China
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 323
- Registration Number
- NCT05309291
- Locations
- 🇨🇳
Baxter Investigational Site, Suzhou, China
Cefazolin PK Study 3g vs 2g
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT05309304
- Locations
- 🇺🇸
Baxter Investigational Site, Baltimore, Maryland, United States
Starling Registry Study
- First Posted Date
- 2020-12-01
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 1207
- Registration Number
- NCT04648293
- Locations
- 🇺🇸
Baxter Investigational Site, Columbus, Ohio, United States
🇺🇸Mercy Hospital St. Louis, Saint Louis, Missouri, United States
🇺🇸Baxter Investigational SIte, Galveston, Texas, United States
Post-Market Study of Low-flow ECCO2R Using PrismaLung+
- Conditions
- Interventions
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT04617093
- Locations
- 🇫🇷
Baxter Investigational Site, Vandœuvre-lès-Nancy, France
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
- Conditions
- Interventions
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 101
- Registration Number
- NCT04555044
- Locations
- 🇺🇸
Baxter Investigational Site, Provo, Utah, United States
Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA
- Conditions
- Interventions
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 26
- Registration Number
- NCT04324593
- Locations
- 🇺🇸
Baxter Investigational Site, Miami, Florida, United States